Greenwich LifeSciences (GLSI)
Runs a single Phase III trial for a peptide vaccine preventing HER2-positive breast cancer recurrence.
$17.51
After hours−0.02 (−0.11%)
At close$17.53(−10.01%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
estimated · in 51 days
EPS estimate
−$0.34
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Aug '25Nov '25Mar '26Jun '26Aug '26Nov '26
Reported−$0.61−$0.25−$0.30−$0.30−$0.32−$0.39−$0.27Pending
Estimate−$0.21−$0.24−$0.24−$0.30−$0.32−$0.33−$0.33−$0.34
Surprise−190.5%−4.2%−25.0%0.0%0.0%−18.2%+18.2%—
RevenueReportedEstimate
Apr '25May '25Aug '25Nov '25Mar '26Jun '26Aug '26Nov '26
Reported$3.6K——————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.29 | — | — |
| Sep 2027 | −$0.29 | — | — |
| Jun 2027 | −$0.29 | — | — |
| Mar 2027 | −$0.30 | — | — |
| Dec 2026 | −$0.35 | — | — |
| Nov 2026 | −$0.34 | — | — |
| Aug 2026 | −$0.33 | −$0.27 | +18.2% |
| Jun 2026 | −$0.33 | −$0.39 | −18.2% |
| Mar 2026 | −$0.32 | −$0.32 | 0.0% |
| Nov 2025 | −$0.30 | −$0.30 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.29 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.29 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.29 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.30 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.35 | — | — | $0 | — | — | — |
| Nov 13, 2026 | −$0.34 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$0.33 | −$0.27 | +18.2% | — | — | — | +0.3% |
| Jun 3, 2026 | −$0.33 | −$0.39 | −18.2% | — | — | — | 0.0% |
| Mar 31, 2026 | −$0.32 | −$0.32 | 0.0% | — | — | — | −4.4% |
| Nov 14, 2025 | −$0.30 | −$0.30 | 0.0% | — | — | — | +1.5% |
| Aug 14, 2025 | |||||||
| May 20, 2025 | |||||||
| Apr 15, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 20, 2024 | |||||||
| Apr 15, 2024 | |||||||
| Oct 19, 2023 | |||||||
| Aug 21, 2023 | |||||||
| May 22, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 20, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 20, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Sep 28, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 |